Viz.ai, an applied artificial intelligence healthcare company focused on time-sensitive conditions, secured $21 million in Series A funding led by Kleiner Perkins, with participation from GV, formerly Google Ventures. Mamoon Hamid, general partner at Kleiner Perkins, will also join the Viz.ai board of directors.
Founded in 2016 by Dr. Chris Mansi and Dr. David Golan, Viz.ai built the first FDA-cleared computer aided triage software to detect and triage urgent stroke cases. The AI cloud-based platform is designed to analyze brain scans for large vessel occlusions, and then to send the scan to a neurovascular specialist to facilitate early therapeutic intervention.
The company plans to use the funding for market expansion and to extend their product portfolio beyond stroke.